Indian drug companies have started developing their own versions of Novo Nordisk’s Wegovy. With some analysts predicting that the weight loss market will reach $100 billion a year or more by the end of the decade, executives at Sun Pharma, Cipla, Dr Reddy’s and Lupin say they have started work on versions of Wegovy.